Luthringer Remy's Form 4 filing
Minerva Neurosciences, Inc. (NERV) · filed May 2, 2023
- Accession no.
- 0001209191-23-026683
- Filed
- May 2, 2023
- Trade date
- Apr 28-May 2, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $105.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Luthringer RemyCIK 0001610384 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Common Stock | AGrant or awardAcquired | +88,077 | $0.00 | $0 | 96,388 | Direct | |
| May 1, 2023 | Common Stock | SSaleDisposed | −23,753 | $3.85 | −$91,449.05 | 72,635 | Direct | |
| May 2, 2023 | Common Stock | SSaleDisposed | −3,641 | $3.76 | −$13,690.16 | 68,994 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.